ChemoCentryx announces approval in Japan of Tavneos for the treatment of ANCA-associated vasculitis
ChemoCentryx, Inc., announced that Kissei Pharmaceutical Co., Ltd. has received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) to market Tavneos™ (avacopan), an orally administered… read more.